Previous studies have shown that fibrinogen-to-albumin ratio (FAR) is a novel prognostic immune biomarker in various diseases. In this study, we investigated the role of FAR in the prognosis of patients with stage IB-IIA cervical cancer (CC). | Preoperative fibrinogen-to-albumin ratio a potential prognostic factor for patients with stage IB-IIA cervical cancer